Access this on-demand version of the DIA Direct Community Webinar hosted by DIA's Regulatory Affairs Community

Post-approval changes are inevitable throughout a drug product's life cycle. Due to the complex regulations in ROW countries (the rest of the world), approval of these post-approval changes usually takes several years globally. The pharmaceutical industry needs a harmonized approach to establish globally recognized standards for change management, streamline regulatory pathways, foster transparency and collaboration, and prioritize patient safety and product quality throughout the process.